Viewing Study NCT00207766


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-01-02 @ 10:02 AM
Study NCT ID: NCT00207766
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease
Sponsor: Centocor, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module